Drug profile · INN
decitabine
DACOGEN
- US status
- approved
- Patents linked
- 2
- News articles
- 0
Quick answer
decitabine (DACOGEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN decitabine
Brand DACOGEN
Route INTRAVENOUS
Formulation INJECTABLE
ATC code L01BC08
Related patents
Search patents →Frequently asked questions
What is decitabine?
decitabine (DACOGEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for decitabine?
DACOGEN is a marketed brand name for decitabine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of decitabine?
decitabine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.